Search
- Report
Chapin White, CBO's Director of Health Analysis, testifies before the House Committee on the Budget.
- Report
CBO analyzed the effects on the budget and the economy of eight scenarios that differ from those underlying the agency’s extended baseline—six that vary economic conditions and two that vary budgetary conditions.
- Presentation
Presentation by Tamara Hayford, CBO’s Deputy Director of Health Analysis, to the Members’ Roundtable of No Patient Left Behind.
- Presentation
Presentation by Phillip Swagel, CBO’s Director, at a conference organized by the Economic Policy Innovation Center and the Paragon Health Institute.
- Report
CBO summarizes recent research findings about Medicare accountable care organizations and the factors that have contributed to or limited their ability to achieve net budgetary savings for the Medicare program.
- Report
The Subcommittee on Health of the House Committee on Energy and Commerce convened a hearing at which Chapin White, CBO’s Director of Health Analysis, testified. This document provides CBO’s answers to questions submitted for the record.
- Report
The House Committee on the Budget convened a hearing at which Phillip L. Swagel, CBO's Director, testified. This document provides CBO’s answers to questions submitted for the record.
- Report
CBO expects to be able to provide an estimated range of the budgetary effects of H.R. 1770, the Equitable Community Access to Pharmacist Services Act, by the end of June 2024.
- Presentation
Presentation by Noelia Duchovny, an analyst in CBO’s Health Analysis Division, at the National Academies’ Roundtable on Obesity Solutions.
- Presentation
Presentation by Chapin White, CBO’s Director of Health Analysis, at the David Rogers Health Policy Colloquium, Weill Cornell Medicine.